Cargando…
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
5′AMP-activated kinase (AMPK) constitutes a hub for cellular metabolic and growth control, thus representing an ideal therapeutic target for prostate cancers (PCas) characterized by increased lipogenesis and activation of mTORC1 pathway. However, whether AMPK activation itself is sufficient to block...
Autores principales: | Zadra, Giorgia, Photopoulos, Cornelia, Tyekucheva, Svitlana, Heidari, Pedram, Weng, Qing Ping, Fedele, Giuseppe, Liu, Hong, Scaglia, Natalia, Priolo, Carmen, Sicinska, Ewa, Mahmood, Umar, Signoretti, Sabina, Birnberg, Neal, Loda, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Backwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3992078/ https://www.ncbi.nlm.nih.gov/pubmed/24497570 http://dx.doi.org/10.1002/emmm.201302734 |
Ejemplares similares
-
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
por: Zadra, Giorgia, et al.
Publicado: (2014) -
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer
por: Zadra, Giorgia, et al.
Publicado: (2019) -
When fat goes down, prostate cancer is on the ropes
por: Zadra, Giorgia, et al.
Publicado: (2019) -
Prostate Cancer Progression: as a Matter of Fats
por: Scaglia, Natalia, et al.
Publicado: (2021) -
Nifedipine Modulates Renal Lipogenesis via the AMPK-SREBP Transcriptional Pathway
por: Lin, Yen-Chung, et al.
Publicado: (2019)